Table 2.
Patient characteristics
| Characteristic | Value |
|---|---|
| Median age, years (range) | 66 (34–80) |
| Sex, n (%) | |
| Male:female | 57 (76):18 (24) |
| PS, n (%) | |
| 0:1 | 61 (81.3):14 (18.6) |
| Histology, n (%) | |
| Adenocarcinoma | 42 (56) |
| Squamous cell carcinoma | 27 (36) |
| Unclassified NSCLC | 5 (6.7) |
| Histology unproved | 1 (1.3) |
| UICC seventh stage, n (%) | |
| IIIA:IIIB | 35 (46.7):40 (53.3) |
| T-stage, n | |
| 0:1:2:3:4 | 3:15:22:16:19 |
| N-stage, n | |
| 0:1:2:3 | 5:7:28:35 |
| Primary site, n | |
| Upper:middle:lower | 41:5:27 |
| Others | 2 |
| Central:peripheral | 23:51 |
| Others | 1 |
| Total dose, n (%) | |
| 60–66 GyRBE/30–33 Fr | 37 (49.3) |
| 70–74 GyRBE/33–37 Fr | 37 (49.3) |
| Others | 1 (1.3) |
| Irradiation technique, n (%) | |
| Broad beam:scanning | 67 (89.3):8 (10.7) |
| Median follow-up time, months | 39.5 (range: 1.6–55.6) |
| Interstitial pneumonia, n | 5 |
| Diabetes, n | 12 |
| Smoking history, n | |
| Nonsmoker | 10 |
| Smoker (Brinkman index < 600) | 16 |
| Smoker (Brinkman index ≥ 600) | 49 |
UICC, Union for International Cancer Control [25].